Corporadelic

Article

Church of Psilomethoxin, Part 1: Sacramental Skepticism. Is the Church in Denial?

This is the first article in a series investigating the Church of Psilomethoxin (CoP), exploring the recent debate about the Church’s sacrament and the people involved in promoting the Church and its claims.

Article

Rick Doblin Is No Longer MAPS’ Executive Director. We Didn’t Notice — Did You?

The Multidisciplinary Association for Psychedelic Studies (MAPS) quietly replaced founder Rick Doblin as Executive Director with Kris Lotlikar.

Article

A Resource for Journalists Covering Sexual Assault in Psychedelic Therapy

Language used by mainstream media affects the way we think about and respond to sexual violence, and no language is neutral. When journalists repeat the misrepresentations of abusers without qualification, they retraumatize victims and perpetuate ongoing misogynistic views about sexual violence.

Article

An open letter in response to John Oliver’s Last Week Tonight episode on Psychedelic Assisted Therapy

Last Week Tonight joined a long and growing list of media outlets that have added fuel to the hype of psychedelic medicalization.

Article

Psychedelic Training Provider Fluence Files Trademark for Common Phrase, Walks Back After Criticism

Fluence will no longer seek a trademark for the phrase “Psychedelic Harm Reduction and Integration.”

Article

A Channel for Magic: Ralph Hood’s Mysticism Scale and the Occult Roots of the Johns Hopkins Psychedelic Research Program

Psychologist Ralph Hood’s study of serpent handling and mysticism helped legitimize the study of psychedelics. So why doesn’t he want them approved for medical use?

Article

How To Open Your Wallet: The Hyped and Distorted Claims of Online Psychedelic Marketing

From cultural appropriation to “Shroom Boom,” psychedelic online marketing gaffes and misrepresentations are becoming more and more prevalent from major psychedelic organizations.

Article

Open Letter to MAPS Canada, MAPS, and MAPS PBC on Data Privacy and Doxxing

Open Letter to MAPS Canada, MAPS, and MAPS PBC on Data Privacy and Doxxing. We believe that an organization responsible for private data, in such close proximity to criminalized subcultures, must take matters of privacy and security seriously.

Article

The Masters of Bad Trips

As proponents of psychedelics begin to grapple with legacies of abuse, it’s time to learn from victims themselves. Psymposia is co-producing an investigative podcast series, Power Trip, with New York Magazine.

Article

MAPS Canada’s Data Breach Foreshadows Corporadelic Future

As the psychedelic pharmaceutical industry increasingly prioritizes personal data extraction through mobile apps, wearables, and so-called “targeted” medicine, a recent data breach by former MAPS Canada Executive Director Mark Haden provides a warning about some of the possible consequences to the…

Article

DoubleBlind Claims Its Ad Was the ‘First-Ever’ U.S. Psychedelic Destigmatization Campaign — It Wasn’t

DoubleBlind claims its recently-unveiled New York City billboard is a lot of things, except what it actually is: a giant advertisement.

Article

COMPASS Pathways’ Psilocybin Patent Questioned By UK Patent Examiner

While COMPASS has issued a response defending the validity of its patents, one of the co-inventors says the patent examiner’s opinion is probably “a valid one.”